2020 ARCC Conference on May 25 and 26
Registration for the 2020 ARCC Conference, which will take place in Saskatoon on May 25 and 26, is NOW OPEN! Click Here to Register. Plenary themes for 2020 include Real World Evidence, Data-Linkage, and Patient Engagement in research. Early-bird rates are in effect until April 17, 2020.
If you are a new professional (within 5 years of receiving your terminal degree) you may be eligible for a special registration code to access this special rate. If you are a patient looking to attend the 2020 ARCC Conference, complementary registration may be available.
The abstract and travel award submission deadline for the 2020 ARCC Conference is Friday January 31st, 2020. The abstract submission site is https://www.events.f2fe.com/arcc/abstract/index.cfm?ID=2IPj5Uf. Travel awards are available for current students, as well as new professionals within 5 years of graduation. Guidelines can be found at https://cc-arcc.ca/wp-content/uploads/2019/10/Abstract-Guidelines_ARCC-2020.pdf.
All questions about the 2020 ARCC Conference as well as information about registration codes and complementary registration can be directed to the Network Manager, Rebecca Mercer at Rebecca.Mercer@cancercare.on.ca.
New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institut... Read More »
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institut... Read More »
The CCRA Board Welcomes Dr. Don Desserud
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at th... Read More »
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at th... Read More »